313 participants
TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-21
- Start Date:
- 2021-09-16
- Completion:
- 2025-12-19
Conditions
- Thyroid Eye Disease
Interventions
- DRUG
No Results Yet